This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Petzelbauer, E. Articles by Madri, J. A. Search for Related Content PubMed PubMed Citation Articles by Petzelbauer, E. Articles by Madri, J. A.

American Journal of Pathology, Vol 149, 923-931, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Role of plasminogen activator inhibitor in the reciprocal regulation of bovine aortic endothelial and smooth muscle cell migration by TGF-beta 1

E Petzelbauer, JP Springhorn, AM Tucker and JA Madri
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06510, USA.

Vascular endothelial and smooth muscle cells exhibit reciprocal migratory responses after transforming growth factor (TGF)-beta 1 treatment. Endothelial cells exhibit a decreased migratory rate and smooth muscle cells exhibit an increased migratory rate. Previous studies have demonstrated increases in extracellular matrix and integrin synthesis and expression in response to TGF-beta 1. In this report, we illustrate the roles of plasminogen activator inhibitor in modulating the migratory rates in these two cell types. Endothelial cells appear to require a proteolytic phenotype for rapid migration, whereas vascular smooth muscle cells appear to require an anti- proteolytic phenotype. Modulation of proteinase/anti-proteinase activity ratios was accomplished via TGF-beta 1 induction, addition of exogenous plasminogen activator inhibitor, addition of anti-catalytic antibodies directed against urokinase plasminogen activator, overexpression of plasminogen activator inhibitor utilizing stable transfectants, and the use of vitronectin as a substratum. The reciprocal migratory behaviors exhibited by these two vascular cell types in response to TGF-beta 1 is discussed in the context that these two vascular cell types utilize distinct adhesive and signaling pathways in their interactions with extracellular matrix components and responsiveness to proteolytic activity.

This article has been cited by other articles:

				H. Hao, G. Gabbiani, and M.-L. Bochaton-Piallat Arterial Smooth Muscle Cell Heterogeneity: Implications for Atherosclerosis and Restenosis Development Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1510 - 1520. [Abstract] [Full Text] [PDF]

				D. Hasenstab, H. Lea, and A. W. Clowes Local Plasminogen Activator Inhibitor Type 1 Overexpression in Rat Carotid Artery Enhances Thrombosis and Endothelial Regeneration While Inhibiting Intimal Thickening Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 853 - 859. [Abstract] [Full Text] [PDF]

				H. Lee, I. Struman, C. Clapp, J. Martial, and R. I. Weiner Inhibition of Urokinase Activity by the Antiangiogenic Factor 16K Prolactin: Activation of Plasminogen Activator Inhibitor 1 Expression Endocrinology, September 1, 1998; 139(9): 3696 - 3703. [Abstract] [Full Text] [PDF]

				R. A. Sobel, J. R. Hinojoza, A. Maeda, and M. Chen Endothelial Cell Integrin Laminin Receptor Expression in Multiple Sclerosis Lesions Am. J. Pathol., August 1, 1998; 153(2): 405 - 415. [Abstract] [Full Text] [PDF]

				M.-L. Bochaton-Piallat, G. Gabbiani, and M. S. Pepper Plasminogen Activator Expression in Rat Arterial Smooth Muscle Cells Depends on Their Phenotype and Is Modulated by Cytokines Circ. Res., June 1, 1998; 82(10): 1086 - 1093. [Abstract] [Full Text] [PDF]